Barclays Maintains Overweight on Cemex, Raises Price Target to $16

Benzinga Newsdesk www.benzinga.com Positive 83.6%

Neg 0% Neu 0% Pos 83.6%

Barclays analyst Benjamin Theurer maintains Cemex (NYSE:CX) with a Overweight and raises the price target from $15 to $16.